TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Artiva Biotherapeutics, Inc. Common Stock (ARTV)

Healthcare Biotechnology
10.80 $
+6.5% vs. previous close
Closing price · As of: 3. Aug 2026

Artiva Biotherapeutics, Inc. Common Stock (ARTV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet ARTV
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
105 90 76 226 210 191 169 149 131 106
80 66 50 151 189 170 149 130 113 89
54 48 34 56 40 30 28 26 27 21
77 62 47 147 185 166 142 123 108 87
1.8 1.7 1.5 0.7 0.1 1.0 0.0 0.9 0.8 0.6
267 265 267 25 23 22 20 20 21 18
12 10 11 13 12 12 11 11 13 11
3.6 3.6 3.8 3.7 3.7 3.7 3.6 3.2 3.1 3.0
0.6 1.5 0.8 1.2 1.1 2.0 1.2 0.8 0.4 2.3
-162 -175 -191 201 187 169 149 129 110 88
-181 -195 -213 -231 -247 -267 -288 -310 -331 -354
18 19 20 18 23 24 24 24 24 24 24 25

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?